Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-11 · accession 0001628280-24-027760 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-12 | 2024-06-11 | VIR | Ramasastry Saira | Dir | S - Sale | $10.95 | -4,000 | 14.6K | -21% | -$43.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | S | D | 4,000 | $10.95 | 14,619 | D | — | — |